References
- Rappuoli R, Miller HI, Falkow S. The intangible value of vaccination. Science297, 93769 (2002).
- Global Alliance For Vaccines and Immunization (GAVI). Fact Sheet 169, March (2001).
- Ehreth JL. The value of vaccination: a global perspective. Vaccine21, 4105–4117 (2003).
- Jamison DT, Mosley WH, Mwasham AR, Bobadilla JL. Disease Control Priorities in developing countries. Oxford University Press, Oxford, UK (1993).
- Miller M, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type B, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. Health Econ.9(1), 19–35 (2000).
- Miller M. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. Pediatr. Infect. Dis. J.17(Suppl.), S152–S159 (1998).
- Graham JD, Thompson KM, Goldie SJ. The cost effectiveness of air bags by seating position. JAMA278, 1418–1425 (1997).
- Tsvat J, Duke D, Goldman L. Cost effectiveness of captopril therapy after myocardial infarction. J. Am. Coll. Cardiol.26, 914–919 (1995).
- Boyle MH, Torrance GW, Sinclair JC. Economic evaluation of neonatal intensive care of very-low-weight infants. N. Engl. J. Med.308(22), 1330–1337 (1983).
- Revicki DA, Brown RE, Palmer W. Modeling the cost effectiveness of antidepressant treatment in primary care. PharmacoEconocomics8, 524–540 (1995).
- Prabhat JHA, Bangoura O, Ranson K. The cost effectivenesss of forty health interventions in Guinea. Health Pol. Plan.13(3) 249–262 (1998).
Websites
- Andrus JK. Vaccinology and immunization www.epibiostat:ucsf:edu/igh/programmes/programmes.html (Accessed January, 2005)
- GAVI: vaccines are cost effective: a summary of recent research www.vaccinealliance.org/text/reference/vacc_cost.html (Accessed January, 2005)